Press release
Global Biopharmaceuticals Market Outlook to 2027: Ken Research
The number of diagnoses with various chronic diseases is growing with each passing year. Every year, many people globally experience disability or death. Cardiovascular diseases, cancer, diabetes & arthritis are considered to be major diseases by Centre for Disease prevention & control. According to the same source, an estimated 859000 Americans die yearly. As mentioned above, the growing incidence of chronic diseases among people promotes the need for biopharmaceuticals & results in market growth.
2. Development of a strong vaccine against COVID has resulted in huge market opportunity for Biopharmaceutical Market globally.
Download a free Sample Report: https://www.kenresearch.com/sample-report.php?Frmdetails=NTk2NDc1
The continuing COVID-19 outbreak is projected to have impact on pharmaceuticals sector. The majority of pharmaceutical firms are working hard to produce vaccines against SARS-COV2. Traditional vaccines such as attenuated & inactivated vaccines are amongst the choices. However, sophisticated protein vaccines, RNA, DNA comprise majority of vaccine candidates. Over the course, this factor is projected to raise the demand of biopharmaceuticals market.
Key Target Audience:
Government
Hospitals
Clinics
Others
Companies Covered:
Johnson & Johnson
Pfizer
Novartis
Merck & Co
Amgen
Bayer
Roche
Cipla
Time Period Captured in the Report:
Historical Period:2017- 2022
Base Year: 2022
Forecast Period: 2022-2027
For more insights on market intelligence, refer to the link below: -
https://www.kenresearch.com/industry-reports/global-bio-pharmaceuticals-market
Related Reports by Ken Research: -
https://www.kenresearch.com/healthcare/pharmaceuticals/australia-pharmacy-retail-market-outlook-to-2025/444312-91.html
https://www.kenresearch.com/healthcare/pharmaceuticals/brazil-pharmaceuticals-market-outlook/303833-91.html
India
Ken Research is a Market Research and Consulting Firm, based out of India, Indonesia and UAE. Since 2011, we have been assisting clients globally with our Syndicate and Bespoke Market Research and Advisory Services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biopharmaceuticals Market Outlook to 2027: Ken Research here
News-ID: 3093867 • Views: …
More Releases from Ken Research Pvt .Ltd
India Shrimp and Red Chilles Market - Ken Research Stated the Sector Valued at ~ …
Comprehensive market analysis maps export expansion, cold-chain investments, and value-added opportunities across India's aquaculture and spices ecosystem
Delhi, India - September 12, 2025 - Ken Research released its strategic market analysis titled "India Shrimp and Red Chilles Market Outlook to 2030," revealing that India's combined shrimp and red chillies market valued at USD 13000 billion, on the most recent market data for shrimp. The comprehensive analysis details how export-oriented aquaculture and…
India TMS Market - Ken Research Stated the Sector Valued at ~INR 4 Crore with St …
Comprehensive market analysis maps defense and aerospace growth trajectory, investment opportunities, and strategic imperatives for industry leaders in India's evolving TMS ecosystem
Delhi, India - September 12, 2025 - Ken Research released its strategic market analysis titled "India TMS Market Outlook to 2029," revealing that India's Test, Measurement & Simulation (TMS) market is valued at ~INR 4 crore and is projected to grow steadily through 2029. The comprehensive analysis details how…
KSA Debt Collection Market Reached ~USD 800 million, Stated Ken Research
Comprehensive market analysis maps regulatory reforms, digital collections acceleration, and strategic imperatives across Saudi Arabia's maturing credit ecosystem
Delhi, India - September 12, 2025 - Ken Research released its strategic market analysis titled "KSA Debt Collection Market Outlook to 2030," revealing that Saudi Arabia's debt collection market valued at ~USD 800 million, -is projected to surpass USD xx billion by 2030. The comprehensive analysis details how placements and recoveries are expected…
KSA Luxury Car Market - Ken Research Stated the Sector Valued at ~USD 4.0 billio …
Comprehensive market analysis maps premium demand trajectory, investment opportunities, and strategic imperatives for industry leaders in the Kingdom's evolving luxury mobility ecosystem
Delhi, India - September 12, 2025 - Ken Research released its strategic market analysis titled "KSA Luxury Car Market Outlook to 2030," revealing that Saudi Arabia's luxury car market is currently valued at USD 4.0 billion and is projected to surpass USD xx billion by 2030. The comprehensive analysis…
More Releases for Biopharmaceutical
Biopharmaceutical third-party logistics Market
Biopharmaceutical Third-Party Logistics Market to reach over USD 176.28 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), Region, Market Outlook And Industry Analysis 2031"
The global Biopharmaceutical third-party logistics market…
Biopharmaceutical Fermentation Market Fueling Biopharmaceutical Innovation: The …
Biopharmaceutical Fermentation Market Worth USD 14.91billion by the year 2030- Exclusive Report by InsightAce Analytic
The newly published report titled "Global Biopharmaceutical Fermentation Market (By Product (Upstream And Downstream Processes), Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, And Others), End-User (Biopharmaceutical Industries, Contract Research
Organizations, Food Industries, Academic Research Institutes, And Others))- Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) And Forecast Till 2030." of InsightAce Analytic Pvt. Ltd.…
Biopharmaceutical Cold Chain Transport Market Temperature-controlled Transport f …
Biopharmaceutical Cold Chain Transport Market 2023 Forecast: Unveiling Opportunities and Growth
Biopharmaceutical Cold Chain Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Cold Chain Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of…
Biopharmaceutical Transport Market Transport Se rvices for Biopharmaceutical Pro …
Biopharmaceutical Transport Market 2023 Forecast: Unveiling Opportunities and Growth
Biopharmaceutical Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including the volume of…
Biopharmaceutical Market Industry Analysis - Biopharmaceutical Market Size Drive …
Acumen Research and Consulting has recently published a research report on the Biopharmaceutical Market for the forecast period of 2022 - 2030, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Biopharmaceutical Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2030.
The research study on the Biopharmaceutical Market analyzes key drivers upholding product sales…
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period
Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial…
